Market Share of Non-Small Cell Lung Cancer (NSCLC) Industry
The non-small cell lung cancer market is fragmented and competitive and consists of several major players. The companies are adopting various key business strategies such as collaborations, partnerships, new product launches and other initiatives to withhold their market position. Some of the key companies in the market are F. Hoffmann-La Roche, AstraZeneca, Bristol-Myers Squibb, Merck, Novartis, Pfizer, Takeda Pharmaceuticals, Bayer Healthcare, Eli Lilly and Company, and GlaxoSmithKline among others.
Non-Small Cell Lung Cancer (NSCLC) Market Leaders
F. Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Pfizer Inc.
AstraZeneca
Novartis AG
*Disclaimer: Major Players sorted in no particular order
